HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Guido Mazzoleni Selected Research
Guido Mazzoleni Research Topics
Disease
14
Neoplasms (Cancer)
01/2022 - 11/2008
5
Malignant Mesothelioma
12/2021 - 01/2018
4
Mesothelioma
12/2021 - 01/2018
4
Carcinoma (Carcinomatosis)
01/2019 - 11/2010
4
Renal Cell Carcinoma (Grawitz Tumor)
05/2018 - 01/2005
2
Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 06/2011
2
Prostatic Neoplasms (Prostate Cancer)
05/2014 - 04/2014
2
Adenocarcinoma
05/2011 - 06/2006
1
Goiter
01/2022
1
Poisoning
08/2021
1
Rare Diseases (Rare Disease)
11/2020
1
Melanoma (Melanoma, Malignant)
09/2020
1
Dental Calculus
12/2018
1
Amyloidosis
06/2018
1
Fat Embolism
06/2018
1
Osteoarthritis
06/2018
1
Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2017
1
Osteoradionecrosis
01/2016
1
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
07/2015
1
Stomach Neoplasms (Stomach Cancer)
05/2015
1
Pancreatic Neoplasms (Pancreatic Cancer)
04/2014
1
Acquired Immunodeficiency Syndrome (AIDS)
01/2014
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2014
1
Margins of Excision
11/2013
1
Extramammary Paget Disease (Paget Disease, Extramammary)
07/2013
1
Neoplasm Metastasis (Metastasis)
05/2011
1
Hepatocellular Carcinoma (Hepatoma)
05/2011
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2011
1
Breast Neoplasms (Breast Cancer)
05/2011
1
Squamous Cell Neoplasms (Squamous Cell Cancer)
05/2011
1
Necrosis
11/2010
1
Diarrhea
08/2010
1
Weight Gain
08/2010
1
Edema (Dropsy)
08/2010
1
Thymoma (Thymic Carcinoma)
11/2008
1
Seminoma
11/2007
Drug/Important Bio-Agent (IBA)
5
Asbestos
IBA
12/2021 - 01/2018
4
Antibodies
IBA
05/2018 - 05/2011
4
Epithelial Cell Adhesion Molecule
IBA
01/2016 - 05/2011
2
Proteins (Proteins, Gene)
FDA Link
01/2016 - 07/2013
2
ErbB Receptors (EGF Receptor)
IBA
06/2011 - 11/2008
1
Iodine
IBA
01/2022
1
human ERBB2 protein
IBA
12/2021
1
Hormones (Hormone)
IBA
12/2021
1
Nitrites
IBA
08/2021
1
Carcinogens
IBA
07/2021
1
Metals
IBA
01/2021
1
MicroRNAs (MicroRNA)
IBA
09/2020
1
Messenger RNA (mRNA)
IBA
09/2020
1
Antigens
IBA
01/2019
1
Catenins
IBA
01/2019
1
Aminopeptidases
IBA
05/2018
1
Transcription Factors (Transcription Factor)
IBA
05/2018
1
Microphthalmia-Associated Transcription Factor
IBA
05/2018
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2017
1
Biomarkers (Surrogate Marker)
IBA
01/2016
1
Tyrosine Kinase Inhibitors
IBA
07/2015
1
Trastuzumab (Herceptin)
FDA Link
05/2015
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
04/2014
1
Tensins
IBA
04/2014
1
anagrelide (Agrylin)
FDA Link
Generic
01/2014
1
Panitumumab (Vectibix)
FDA Link
06/2011
1
Cetuximab (Erbitux)
FDA Link
06/2011
1
Triglycerides (Triacylglycerol)
IBA
08/2010
1
Solutions
IBA
11/2008
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
11/2008
1
Imatinib Mesylate (Gleevec)
FDA Link
11/2007
1
Kalinin
IBA
06/2006
1
Eosine Yellowish-(YS) (Eosin)
IBA
06/2006
1
Hematoxylin (Haematoxylon)
IBA
06/2006
Therapy/Procedure
3
Nephrectomy
11/2013 - 01/2005
2
Therapeutics
05/2015 - 01/2014
1
Thyroidectomy
01/2022
1
Conservative Treatment
01/2022
1
Operative Surgical Procedures
01/2022
1
Oral Hygiene (Dental Hygiene)
12/2018
1
Hip Replacement Arthroplasty (Total Hip Replacement)
06/2018
1
Arthroplasty
06/2018
1
Radiotherapy
01/2016
1
Brachytherapy
04/2014
1
Nephroureterectomy
11/2010
1
Adjuvant Chemotherapy
11/2010
1
Fat-Restricted Diet (Diet, Fat Restricted)
08/2010
1
Aftercare (After-Treatment)
11/2007